A new antirhinovirus compound, ICI 73602: structure, properties, and spectrum of activity.
作者信息
Swallow D L, Bucknall R A, Stanier W E, Hutchinson A, Gaskin H
出版信息
Ann N Y Acad Sci. 1977 Mar 4;284(1):305-9. doi: 10.1111/j.1749-6632.1977.tb21965.x.
Abstract
摘要
相似文献
1
A new antirhinovirus compound, ICI 73602: structure, properties, and spectrum of activity.一种新型抗鼻病毒化合物ICI 73602：结构、性质及活性谱
Ann N Y Acad Sci. 1977 Mar 4;284(1):305-9. doi: 10.1111/j.1749-6632.1977.tb21965.x.
2
Antirhinovirus activity of 6-anilino-9-benzyl-2-chloro-9H-purines.
J Med Chem. 1990 May;33(5):1360-3. doi: 10.1021/jm00167a012.
3
Synthesis and antirhinovirus activity of 6-(dimethylamino)-2-(trifluoromethyl)-9-(substituted benzyl)-9H-purines.
J Med Chem. 1989 Aug;32(8):1757-63. doi: 10.1021/jm00128a016.
4
9-Benzyl-6-(dimethylamino)-9H-purines with antirhinovirus activity.
J Med Chem. 1988 Oct;31(10):2001-4. doi: 10.1021/jm00118a025.
5
Inhibition of rhinovirus RNA synthesis in diploid cells by a substituted guanidine compound having a different mode of action from guanidine.
J Gen Virol. 1974 Jun;23(3):341-5. doi: 10.1099/0022-1317-23-3-341.
6
3,4-Dihydro-2-phenyl-2H-pyrano[2,3-b]pyridines with potent antirhinovirus activity.
J Med Chem. 1986 Sep;29(9):1590-5. doi: 10.1021/jm00159a006.
7
A comparative test of fifteen compounds against all known human rhinovirus serotypes as a basis for a more rational screening program.针对所有已知人类鼻病毒血清型对15种化合物进行的比较试验，作为更合理筛选方案的基础。
Antiviral Res. 1991 Oct;16(3):213-25. doi: 10.1016/0166-3542(91)90001-8.
8
Studies on 44 081 R.P., a new antirhinovirus compound, in cell cultures and in volunteers.对新型抗鼻病毒化合物44 081 R.P.进行的细胞培养和志愿者研究。
Antimicrob Agents Chemother. 1985 May;27(5):846-50. doi: 10.1128/AAC.27.5.846.
9
RMI 15,731 (1-[5-tetradecyloxy-2-furanyl]-ethanone), a new antirhinovirus compound.RMI 15731（1-[5-十四烷氧基-2-呋喃基]-乙酮），一种新型抗鼻病毒化合物。
Antimicrob Agents Chemother. 1979 Sep;16(3):301-5. doi: 10.1128/AAC.16.3.301.
10
Quantum QSAR of the antirhinoviral activity of 9-benzylpurines.9-苄基嘌呤抗鼻病毒活性的量子定量构效关系
Drug Des Deliv. 1991;7(3):227-39.
引用本文的文献
1
Antiviral activity of sodium 5-aminosulfonyl-2,4-dichlorobenzoate (M12325).5-氨基磺酰基-2,4-二氯苯甲酸钠（M12325）的抗病毒活性
Antimicrob Agents Chemother. 1982 Aug;22(2):250-4. doi: 10.1128/AAC.22.2.250.
本文引用的文献
1
SPECIFIC INHIBITION OF REPLICATION OF ANIMAL VIRUSES.动物病毒复制的特异性抑制
Science. 1963 Oct 4;142(3588):24-33. doi: 10.1126/science.142.3588.24.
2
Genetic recombination with poliovirus type 1. Studies of crosses between a normal horse serum-resistant mutant and several guanidine-resistant mutants of the same strain.与1型脊髓灰质炎病毒的基因重组。同一毒株的正常抗马血清突变体与几种抗胍突变体之间杂交的研究。
Virology. 1963 May;20:107-19. doi: 10.1016/0042-6822(63)90145-4.
3
The continuing search for antiviral drugs.
Adv Pharmacol Chemother. 1973;11:295-318.
4
The use of inhibitors in the study of picornavirus genetics.
Prog Med Virol. 1972;14:123-99.
5
A novel substituted guanidine with high activity in vitro against rhinoviruses.一种新型取代胍，在体外对鼻病毒具有高活性。
Nature. 1973 Nov 16;246(5429):144-5. doi: 10.1038/246144a0.
6
The effects of substituted benzimidazoles on the growth of viruses and the nucleic acid metabolism of host cells.
J Gen Virol. 1967 Jan;1(1):89-99. doi: 10.1099/0022-1317-1-1-89.
7
In vitro polio virus inhibition by two guanidino-pyrimidines.两种胍基嘧啶对脊髓灰质炎病毒的体外抑制作用
Experientia. 1964 Jan 15;20(1):12-3. doi: 10.1007/BF02146013.
Zotero 插件